Roger Franklin

Director/Board Member at ABLIVA AB

47 year

Health Technology

Finance

Consumer Services

Profile

Roger Franklin is currently the Director at Abliva AB. He also holds positions as Director at Gesynta Pharma AB, TargED Biopharmaceuticals BV, Crosslanes Holding AB, and Complement Therapeutics GmbH.
Additionally, he is the Deputy Director at HVentures Capital i AB, HVentures Capital II AB, HVentures AB, and Partner at Hadean Ventures AS.
Previously, he worked as Deputy Director at SAGA Diagnostics AB and Analyst at Panmure Liberum Capital Ltd. from 2010 to 2018.
Dr. Franklin obtained an undergraduate degree from the University of Oxford and a doctorate from the University of Cambridge.

Roger Franklin active positions

Companies	Position	Start
ABLIVA AB	Director/Board Member	20/05/2020
Hadean Ventures AS Hadean Ventures AS Investment ManagersFinance Hadean Ventures invests in life science companies across Europe with a particular focus on the Nordic region. The firm targets companies operating in the fields of pharmaceuticals, biotech, medical technology, diagnostics, and digital health. The firm provides financing for early stage capital requirements and also makes co-investments.	Private Equity Investor	-
Gesynta Pharma AB Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions	Director/Board Member	-
Crosslanes Holding AB	Director/Board Member	-
TargED Biopharmaceuticals BV TargED Biopharmaceuticals BV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops biological drugs to improve treatment of thrombosis	Director/Board Member	-
HVentures Capital i AB HVentures Capital i AB Investment ManagersFinance Provides private equity fund services	Corporate Officer/Principal	-
HVentures Capital II AB HVentures Capital II AB Investment ManagersFinance Functions as a venture capital fund	Corporate Officer/Principal	-

All active positions of Roger Franklin

Former positions of Roger Franklin

Companies	Position	End
Liberum Capital Ltd. Liberum Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	31/10/2018
SAGA Diagnostics AB SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance	Corporate Officer/Principal	-

See the detail of Roger Franklin's experience

Training of Roger Franklin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roger Franklin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Abliva AB Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases	Health Technology
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Liberum Capital Ltd. Liberum Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services	Finance
SAGA Diagnostics AB SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance	Health Technology
Hadean Ventures AS Hadean Ventures AS Investment ManagersFinance Hadean Ventures invests in life science companies across Europe with a particular focus on the Nordic region. The firm targets companies operating in the fields of pharmaceuticals, biotech, medical technology, diagnostics, and digital health. The firm provides financing for early stage capital requirements and also makes co-investments.	Finance
Gesynta Pharma AB Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions	Health Technology
HVentures Capital i AB HVentures Capital i AB Investment ManagersFinance Provides private equity fund services	Finance
TargED Biopharmaceuticals BV TargED Biopharmaceuticals BV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops biological drugs to improve treatment of thrombosis	Health Technology
HVentures Capital II AB HVentures Capital II AB Investment ManagersFinance Functions as a venture capital fund	Finance
Crosslanes Holding AB